Amgen (AMGN) Payout Ratio (2011 - 2026)
Amgen (AMGN) posted Payout Ratio of 0.57 for Q2 2026, down 23.18% on a QoQ basis from 0.75 in Q1 2026, and down 35.84% year-over-year from 0.89 in Q2 2025.
Analysis
Amgen (AMGN) Payout Ratio (2011 - 2026) Analysis & Trends
Amgen has reported Payout Ratio for 16 years, with the latest figure at 0.57 in Q2 2026.
- On a quarterly basis, Payout Ratio fell 35.84% year-over-year to 0.57 in Q2 2026; TTM through Jun 2026 was 0.6, a 19.56% decrease from a year earlier, with the FY2025 full-year figure at 0.66, down 43.75% from the prior year.
- Payout Ratio was 0.57 for Q2 2026 at Amgen, down from 0.75 in the prior quarter.
- The five-year high for Payout Ratio was 1.92 in Q4 2024, with the low at 10.69 in Q1 2024.
- Average Payout Ratio over 5 years is 0.2, with a median of 0.74 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Payout Ratio soared 130.95% in 2023, then slumped 2771.16% in 2024.
- Over 5 years, Payout Ratio stood at 0.64 in 2022, then soared by 130.95% to 1.49 in 2023, then climbed by 29.3% to 1.92 in 2024, then slumped by 49.92% to 0.96 in 2025, then slumped by 40.42% to 0.57 in 2026.
- The last three Payout Ratio figures came in at 0.57 (Q2 2026), 0.75 (Q1 2026), and 0.96 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Insmed | 27.99 Bn | 26.83 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.57 |
| Mar 31, 2026 | 0.75 |
| Dec 31, 2025 | 0.96 |
| Sep 30, 2025 | 0.40 |
| Jun 30, 2025 | 0.89 |
| Mar 31, 2025 | 0.74 |
| Dec 31, 2024 | 1.92 |
| Sep 30, 2024 | 0.43 |
| Jun 30, 2024 | 1.62 |
| Mar 31, 2024 | -10.69 |
| Dec 31, 2023 | 1.49 |
| Sep 30, 2023 | 0.66 |
| Jun 30, 2023 | 0.83 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 0.64 |
| Sep 30, 2022 | 0.48 |
| Jun 30, 2022 | 0.79 |
| Mar 31, 2022 | 0.73 |
| Dec 31, 2021 | 0.52 |
| Sep 30, 2021 | 0.53 |